CervoMed Inc. Cost of Revenue
CervoMed Inc. (CRVO) reported Cost of Revenue of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-20.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2014-05-20
- CervoMed Inc. cost of revenue for the quarter ending 2014-03-31 was $0.00.
- CervoMed Inc. cost of revenue for the quarter ending 2013-12-31 was $0.00.
- CervoMed Inc. cost of revenue for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. cost of revenue for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. cost of revenue for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CervoMed Inc. cost of revenue for fiscal 2012 was $235.80K, a 89.79% decline from fiscal 2011.
- CervoMed Inc. cost of revenue for fiscal 2011 was $2.31M, a 997.28% increase from fiscal 2010.
- CervoMed Inc. cost of revenue for fiscal 2010 was $210.39K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-20 | $0.00 derived: sum of 2 quarters · filed 2014-05-20 | $0.00 derived: sum of 3 quarters · filed 2014-05-20 | ||
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $0.00 derived: sum of 2 quarters · filed 2014-04-23 | $0.00 10-K/A · filed 2014-04-23 | ||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 | $0.00 10-Q · filed 2013-11-19 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-20 | $0.00 derived: sum of 2 quarters · filed 2014-05-20 | $850.00 derived: sum of 3 quarters · filed 2014-05-20 | $1.70K derived: sum of 4 quarters · filed 2014-05-20 | |
| 2012-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $850.00 derived: sum of 2 quarters · filed 2014-04-23 | $1.70K derived: sum of 3 quarters · filed 2014-04-23 | $235.80K 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | $850.00 10-Q · filed 2012-11-19 | $1.70K derived: sum of 2 quarters · filed 2013-11-19 | $235.80K 10-Q · filed 2013-11-19 | $2.29M derived: sum of 4 quarters · filed 2013-11-19 | |
| 2012-06-30 | $850.00 10-Q · filed 2013-11-19 | $6.45K 10-Q/A · filed 2012-09-07 | $234.95K 10-Q · filed 2013-08-14 | $2.28M derived: sum of 3 quarters · filed 2013-11-19 | $2.54M derived: sum of 4 quarters · filed 2013-11-19 |
| 2012-03-31 | $228.50K 10-Q/A · filed 2013-05-20 | $2.28M derived: sum of 2 quarters · filed 2013-05-20 | $2.54M derived: sum of 3 quarters · filed 2013-05-20 | $2.54M derived: sum of 4 quarters · filed 2013-05-20 | |
| 2011-12-31 | $2.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | $2.31M derived: sum of 2 quarters · filed 2013-04-24 | $2.31M derived: sum of 3 quarters · filed 2013-04-24 | $2.31M 10-K/A · filed 2013-04-24 | |
| 2011-09-30 | $253.81K 10-Q · filed 2012-11-19 | $253.81K derived: sum of 2 quarters · filed 2012-11-19 | $253.81K 10-Q · filed 2012-11-19 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-16 | $0.00 10-Q · filed 2011-08-16 | |||
| 2010-12-31 | $210.39K 10-K · filed 2012-05-21 | ||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-16 | $0.00 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |